对青素的延迟过敏反应可能会丢失 (并获得):长时间口服挑测试后皮肤测试复敏化
1Department of Dermatology, Singapore General Hospital, Singapore.
Asia Pacific allergy
|December 4, 2025
概括
延迟的β-乳糖过敏可能是短暂的,皮肤测试显示反应能力的减少,然后增加. 这表明T细胞介导的机制可能是药物过敏反应波动的基础.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对β-乳糖抗生素的延迟过敏反应很常见.
- 这些过敏状态的持续时间和稳定性尚未完全理解.
- 皮肤检测是对β-乳糖过敏的关键诊断工具.
研究的目的:
- 为了研究延迟对β-乳酸盐过敏的动态性质.
- 探索过渡性过敏症背后的免疫机制.
- 举报一个案例,说明过敏的损失和随后的收益.
主要方法:
- 病例报告详细介绍了患者对β-乳糖抗生素的反应.
- 用青素进行连续延迟型过敏性皮肤测试.
- 长时间的毒品挑战.
- 皮肤测试反应和后续的临床观察.
主要成果:
- 最初的皮肤测试和挑战表明,延迟过敏性丧失.
- 四周后重复皮肤测试显示阳性.
- 患者患有后炎性超色素,这是皮肤检测后罕见的发现.
结论:
- 延迟的β-乳糖过敏可以是一个动态的,可逆的条件.
- 长期挑战后的积极性可能涉及T细胞的原始化和回归到皮肤.
- 后炎性超色素可能表明T细胞介导的机制类似于固定的药物喷发.
相关概念视频
Hypersensitivities
7.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.1K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions
31.9K
Overview
31.9K
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Cross-reactivity
32.8K
Overview
32.8K


